Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Infectious Diseases

Novel Ranking System for Identifying Efficacious Anti-Influenza Virus PB2 Inhibitors

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2015

English

Apotransferrin in Combination With Ciprofloxacin Slows Bacterial Replication, Prevents Resistance Amplification, and Increases Antimicrobial Regimen Effect

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2019

English

Updated Prevalence of McR-Like Genes Among Escherichia Coli and Klebsiella Pneumoniae in SENTRY Program and Characterization of McR-1.11 Variant

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2019

English

Revisiting Activation of and the Mechanism of Resistance to the Compound IQG-607 inMycobacterium Tuberculosis

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2017

English

Distinct Phenotypes Caused by Mutation of MSH2 in Trypanosome Insect and Mammalian Life Cycle Forms Are Associated With Parasite Adaptation to Oxidative Stress

PLoS Neglected Tropical Diseases

English

An Adenovirus Serotype 2-Vectored Ebolavirus Vaccine Generates Robust Antibody and Cell-Mediated Immune Responses in Mice and Rhesus Macaques

Emerging Microbes and Infections

English

Novel Protease Inhibitors Containing C-5-Modified Bis-THF and Aminobenzothiazole as P2 and P2′ Ligands That Exert Potent Antiviral Activity Against Highly Multidrug-Resistant HIV-1 With High Genetic Barrier Against the Emergence of Drug Resistance.

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2019

English

The Anti-Staphylococcal Lysin, CF-301, Activates Key Host Factors in Human Blood to Potentiate MRSA Bacteriolysis

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2019

English

Association Between Self-Reported Adherence and HIV Viral Load Suppression Among Older Children and Adolescents

Journal of Acquired Immune Deficiency Syndromes

Infectious Diseases

Pharmacology

2017

English

In Vitro Activity of a Novel Antifungal Compound, MYC-053, Against Clinically Significant Antifungal-Resistant Strains of Candida Glabrata, Candida Auris, Cryptococcus Neoformans, and Pneumocystis Spp.

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2019

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Infectious Diseases

Novel Ranking System for Identifying Efficacious Anti-Influenza Virus PB2 Inhibitors

Apotransferrin in Combination With Ciprofloxacin Slows Bacterial Replication, Prevents Resistance Amplification, and Increases Antimicrobial Regimen Effect

Updated Prevalence of McR-Like Genes Among Escherichia Coli and Klebsiella Pneumoniae in SENTRY Program and Characterization of McR-1.11 Variant

Revisiting Activation of and the Mechanism of Resistance to the Compound IQG-607 inMycobacterium Tuberculosis

Distinct Phenotypes Caused by Mutation of MSH2 in Trypanosome Insect and Mammalian Life Cycle Forms Are Associated With Parasite Adaptation to Oxidative Stress

An Adenovirus Serotype 2-Vectored Ebolavirus Vaccine Generates Robust Antibody and Cell-Mediated Immune Responses in Mice and Rhesus Macaques

Novel Protease Inhibitors Containing C-5-Modified Bis-THF and Aminobenzothiazole as P2 and P2′ Ligands That Exert Potent Antiviral Activity Against Highly Multidrug-Resistant HIV-1 With High Genetic Barrier Against the Emergence of Drug Resistance.

The Anti-Staphylococcal Lysin, CF-301, Activates Key Host Factors in Human Blood to Potentiate MRSA Bacteriolysis

Association Between Self-Reported Adherence and HIV Viral Load Suppression Among Older Children and Adolescents

In Vitro Activity of a Novel Antifungal Compound, MYC-053, Against Clinically Significant Antifungal-Resistant Strains of Candida Glabrata, Candida Auris, Cryptococcus Neoformans, and Pneumocystis Spp.